AQP4 and neuromyelitis optica: In total, 55.2% of the NMOSD patients (NMO:LETM: ON=57:8:4) were AQP4-ab single positive, and 11.2% of patients (NMO:LETM:ON=8:6:0) were MOG-ab single positive.